No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult danes

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Gjesing, Anette P ^a   Sparsø, Thomas ^a   Borch Johnsen, Knut ^b,f   Jørgensen, Torben ^c,d   Pedersen, Oluf ^a,c,f   Hansen, Torben ^a,g   Olsen, Niels V ^c,e  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e Mental Health Center Glostrup   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR 2; UNCLASSIFIED DRUG; BETA 2 ADRENERGIC RECEPTOR;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CONTROLLED STUDY; DENMARK; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PHYSIOLOGY; QUANTITATIVE TRAIT LOCUS;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; DENMARK; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; QUANTITATIVE TRAIT LOCI; RECEPTORS, ADRENERGIC, BETA-2;

EID: 70349675425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007206     Document Type: Article

References (12)

1. Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, et al. (2003) Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 42: 685-92.
2. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, et al. (2001) Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37: 1303-8.
3. 2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 subjects. Diabetologia 50: 563-568.
4. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, et al. (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97: 10483-10488.
5. Eriksson P, Dahlman I, Rydén M, Hoffstedt J, Arner P (2004) Relationship between b-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes 28: 185-190.
6. Cerrone GE, Pérez MS, Caputo M, Targovnik HM, Frechtel GD (2007) A simple method for the identification of three major haplotypes of the beta2AR. Mol Cell Probes 21: 222-225.
7. Binder A, Garcia E, Wallace C, Kazeem G, Ben-Shlomo Y, et al. (2006) Haplotypes of the beta-2 adrenergic receptor associate with diastolic blood pressure in the Caerphilly prospective study. J Hypertens 24: 471-477.
8. Jørgensen T, Borch-Johnsen K, Thomsen TF, et al. (2003) A randomized nonpharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prevention Rehab 10: 377-386.
9. Gjesing AP, Andersen G, Albrechtsen A, Glümer C, Borch-Johnsen K, et al. (2007) Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med 24: 392-7.
10. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
11. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J hum Genet 68: 978-989.
12. Stephens M, Scheet P (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76: 449-462.